A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children

NCT03292588 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
335
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators